Loading ...Posts Tagged ‘neurontin’
Freedom from Crooked Pharmaceutical Companies
Three Cheers for the prestigious New England Journal of Medicine! They are one of the first mainstream publications to blow the whistle on greedy pharmaceutical executives who drive up sales by pushing doctors to prescribe dangerous drugs for off-label (non-approved) use. The corruption of these white collar drug pushers is so out of control that the journal authors stated, “drastic action is essential to preserve the integrity of medical science and practice and to justify public trust.” 1
This very revealing statement underscores a sad fact that has been apparent to many of us for some time — the whole medical profession is on the brink of a meltdown thanks to the greed and unethical marketing practices of Big Pharma.
The motivating factor in this latest drug company scandal involves the Parke-Davis/Pfizer drug Neurontin, which was introduced in 1993 to a relatively narrow market —individuals affected with a specific seizure condition called partial complex seizures. Two years after its introduction, Neurontin’s 1995 sales were a respectable $98 million. By 2004 however, that number jumped to an astounding $3 billion.2 As you might guess, this tremendous spike in sales was not related to an increase in people suffering from seizures.
